Jan 24, 2025
Loading...
seen from China
seen from Brazil
seen from United States
seen from Brazil
seen from United States
seen from United States
seen from China
seen from Poland
seen from Canada
seen from Yemen
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from Netherlands
seen from United States
seen from United States
seen from United States
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
you know i can see you right
xtwapowis uwu
hey hi how's it going
CipherTrace, which helps track crypto crimes and sells compliance tools, raises $27.1M Series B (Danny Nelson/CoinDesk)
Danny Nelson / CoinDesk: CipherTrace, which helps track crypto crimes and sells compliance tools, raises $27.1M Series B — The hedge funder’s latest crypto bet adds fuel to CipherTrace’s growing crypto compliance and investigations business. — CipherTrace, a security firm that tracks crypto crimes … Source link
View On WordPress
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
GV co-leads $27.1M Series A in Oxford Uni life sciences... - https://wp.me/p8XyML-ges - #271M, #Coleads, #GV, #Life, #Oxford, #Sciences, #Series, #Tech, #Uni
GV co-leads $27.1M Series A in Oxford Uni life sciences spinout Vaccitech
Leaning on its in-house life sciences experience GV has backed one other biotech startup within the UK, co-leading a £20 million ($27.1M) Collection A in Oxford College spinout Vaccitech, which is growing a common flu vaccine. Read More
View On WordPress
GV co-leads $27.1M Series A in Oxford Uni life sciences spinout Vaccitech
Leaning on its in-house life sciences expertise GV has backed another biotech startup within the UK, co-leading a £20 million ($27.1M) Sequence A in Oxford College spinout Vaccitech, which is creating a common flu vaccine.
Sequoia China, one other new investor, can also be co-leading the spherical, together with current backer Oxford Sciences Innovation (OSI) — which operates a fund that…
View On WordPress